This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Alopecia Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Disease Type (Alopecia Areata, Androgenic Alopecia, Alopecia Totalis, Ciatricial Alopecia, Traction Alopecia) ; Drug Type (Minoxidil, Finasteride, Other Drug Types) ; Route of Administration (Oral, Topical, Injectable) ; Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies) , and Geography
Alopecia is a medical term, which is generally used for hair loss. It is a common autoimmune disorder that often results in unpredictable hair loss, which can lead to complete loss of hair on the scalp or, in uttermost cases, the entire body. This extreme condition can affect anyone irrespective of gender and age. Medications such as Minoxidil or Rogaine are the topical agents that are used for the treatment of disease. Other treatments of alopecia include medications that are sometimes used for other autoimmune disorders.
MARKET DYNAMICS
The alopecia market is anticipated to grow in the forecast, owing to the increasing prevalence of alopecia areata and Rise in incidence of chronic disorders such as, cancer, polycystic ovary syndrome (PCOS), hyperthyroidism, hypothyroidism, acute stress disorder, hypopituitarism, lupus. However, the rising awareness among people about hair loss is likely to add novel opportunities in the forecast period.
MARKET SCOPE
The "Global Alopecia Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of alopecia market with detailed market segmentation by disease type, drug type, route of administration, distribution channel and geography. The global alopecia market is expected to witness high growth during the forecast period. The report provides key information on the market status of the leading alopecia market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global alopecia market is segmented on the basis of disease type, drug type, route of administration and distribution channel. Based on disease type, the market is classified as, alopecia areata, androgenic alopecia, alopecia totalis, ciatricial alopecia and traction alopecia. Based on the drug type, the market is segmented into minoxidil, finasteride and other drug types. On the basis of route of administration, the market is categorized as oral, topical and injectable. Based on the distribution channel, the market is segmented as hospitals, retail pharmacies and online pharmacies.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global alopecia market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The alopecia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting alopecia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the alopecia market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the alopecia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from alopecia market are anticipated to have lucrative growth opportunities in the future with the rising demand for alopecia market in the global market. Below mentioned is the list of few companies engaged in the alopecia market.
The report also includes the profiles of key alopecia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
CAPILLUS
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Merck and Co., Inc.
Transitions Hair
Follica, Inc.
Johnson and Johnson Services, Inc.
Concert Pharmaceuticals
HCell Inc.
GlaxoSmithKline plc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Alopecia Market - By Disease Type 1.3.2 Alopecia Market - By Drug Type 1.3.3 Alopecia Market - By Route of Administration 1.3.4 Alopecia Market - By Distribution Channel 1.3.5 Alopecia Market - By Region 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALOPECIA MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS
6. ALOPECIA MARKET - GLOBAL MARKET ANALYSIS 6.1. ALOPECIA - GLOBAL MARKET OVERVIEW 6.2. ALOPECIA - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE
7. ALOPECIA MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE 7.1. OVERVIEW 7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS 7.3. ALOPECIA AREATA 7.3.1. Overview 7.3.2. Alopecia Areata Market Forecast and Analysis 7.4. ANDROGENIC ALOPECIA 7.4.1. Overview 7.4.2. Androgenic Alopecia Market Forecast and Analysis 7.5. ALOPECIA TOTALIS 7.5.1. Overview 7.5.2. Alopecia Totalis Market Forecast and Analysis 7.6. CIATRICIAL ALOPECIA 7.6.1. Overview 7.6.2. Ciatricial Alopecia Market Forecast and Analysis 7.7. TRACTION ALOPECIA 7.7.1. Overview 7.7.2. Traction Alopecia Market Forecast and Analysis
8. ALOPECIA MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE 8.1. OVERVIEW 8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS 8.3. MINOXIDIL 8.3.1. Overview 8.3.2. Minoxidil Market Forecast and Analysis 8.4. FINASTERIDE 8.4.1. Overview 8.4.2. Finasteride Market Forecast and Analysis 8.5. OTHER DRUG TYPES 8.5.1. Overview 8.5.2. Other Drug Types Market Forecast and Analysis
9. ALOPECIA MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION 9.1. OVERVIEW 9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS 9.3. ORAL 9.3.1. Overview 9.3.2. Oral Market Forecast and Analysis 9.4. TOPICAL 9.4.1. Overview 9.4.2. Topical Market Forecast and Analysis 9.5. INJECTABLE 9.5.1. Overview 9.5.2. Injectable Market Forecast and Analysis
10. ALOPECIA MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL 10.1. OVERVIEW 10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS 10.3. HOSPITALS 10.3.1. Overview 10.3.2. Hospitals Market Forecast and Analysis 10.4. RETAIL PHARMACIES 10.4.1. Overview 10.4.2. Retail Pharmacies Market Forecast and Analysis 10.5. ONLINE PHARMACIES 10.5.1. Overview 10.5.2. Online Pharmacies Market Forecast and Analysis
11. ALOPECIA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 11.1. NORTH AMERICA 11.1.1 North America Alopecia Market Overview 11.1.2 North America Alopecia Market Forecasts and Analysis 11.1.3 North America Alopecia Market Forecasts and Analysis - By Disease Type 11.1.4 North America Alopecia Market Forecasts and Analysis - By Drug Type 11.1.5 North America Alopecia Market Forecasts and Analysis - By Route of Administration 11.1.6 North America Alopecia Market Forecasts and Analysis - By Distribution Channel 11.1.7 North America Alopecia Market Forecasts and Analysis - By Countries 11.1.7.1 United States Alopecia Market 11.1.7.1.1 United States Alopecia Market by Disease Type 11.1.7.1.2 United States Alopecia Market by Drug Type 11.1.7.1.3 United States Alopecia Market by Route of Administration 11.1.7.1.4 United States Alopecia Market by Distribution Channel 11.1.7.2 Canada Alopecia Market 11.1.7.2.1 Canada Alopecia Market by Disease Type 11.1.7.2.2 Canada Alopecia Market by Drug Type 11.1.7.2.3 Canada Alopecia Market by Route of Administration 11.1.7.2.4 Canada Alopecia Market by Distribution Channel 11.1.7.3 Mexico Alopecia Market 11.1.7.3.1 Mexico Alopecia Market by Disease Type 11.1.7.3.2 Mexico Alopecia Market by Drug Type 11.1.7.3.3 Mexico Alopecia Market by Route of Administration 11.1.7.3.4 Mexico Alopecia Market by Distribution Channel 11.2. EUROPE 11.2.1 Europe Alopecia Market Overview 11.2.2 Europe Alopecia Market Forecasts and Analysis 11.2.3 Europe Alopecia Market Forecasts and Analysis - By Disease Type 11.2.4 Europe Alopecia Market Forecasts and Analysis - By Drug Type 11.2.5 Europe Alopecia Market Forecasts and Analysis - By Route of Administration 11.2.6 Europe Alopecia Market Forecasts and Analysis - By Distribution Channel 11.2.7 Europe Alopecia Market Forecasts and Analysis - By Countries 11.2.7.1 Germany Alopecia Market 11.2.7.1.1 Germany Alopecia Market by Disease Type 11.2.7.1.2 Germany Alopecia Market by Drug Type 11.2.7.1.3 Germany Alopecia Market by Route of Administration 11.2.7.1.4 Germany Alopecia Market by Distribution Channel 11.2.7.2 France Alopecia Market 11.2.7.2.1 France Alopecia Market by Disease Type 11.2.7.2.2 France Alopecia Market by Drug Type 11.2.7.2.3 France Alopecia Market by Route of Administration 11.2.7.2.4 France Alopecia Market by Distribution Channel 11.2.7.3 Italy Alopecia Market 11.2.7.3.1 Italy Alopecia Market by Disease Type 11.2.7.3.2 Italy Alopecia Market by Drug Type 11.2.7.3.3 Italy Alopecia Market by Route of Administration 11.2.7.3.4 Italy Alopecia Market by Distribution Channel 11.2.7.4 Spain Alopecia Market 11.2.7.4.1 Spain Alopecia Market by Disease Type 11.2.7.4.2 Spain Alopecia Market by Drug Type 11.2.7.4.3 Spain Alopecia Market by Route of Administration 11.2.7.4.4 Spain Alopecia Market by Distribution Channel 11.2.7.5 United Kingdom Alopecia Market 11.2.7.5.1 United Kingdom Alopecia Market by Disease Type 11.2.7.5.2 United Kingdom Alopecia Market by Drug Type 11.2.7.5.3 United Kingdom Alopecia Market by Route of Administration 11.2.7.5.4 United Kingdom Alopecia Market by Distribution Channel 11.3. ASIA-PACIFIC 11.3.1 Asia-Pacific Alopecia Market Overview 11.3.2 Asia-Pacific Alopecia Market Forecasts and Analysis 11.3.3 Asia-Pacific Alopecia Market Forecasts and Analysis - By Disease Type 11.3.4 Asia-Pacific Alopecia Market Forecasts and Analysis - By Drug Type 11.3.5 Asia-Pacific Alopecia Market Forecasts and Analysis - By Route of Administration 11.3.6 Asia-Pacific Alopecia Market Forecasts and Analysis - By Distribution Channel 11.3.7 Asia-Pacific Alopecia Market Forecasts and Analysis - By Countries 11.3.7.1 Australia Alopecia Market 11.3.7.1.1 Australia Alopecia Market by Disease Type 11.3.7.1.2 Australia Alopecia Market by Drug Type 11.3.7.1.3 Australia Alopecia Market by Route of Administration 11.3.7.1.4 Australia Alopecia Market by Distribution Channel 11.3.7.2 China Alopecia Market 11.3.7.2.1 China Alopecia Market by Disease Type 11.3.7.2.2 China Alopecia Market by Drug Type 11.3.7.2.3 China Alopecia Market by Route of Administration 11.3.7.2.4 China Alopecia Market by Distribution Channel 11.3.7.3 India Alopecia Market 11.3.7.3.1 India Alopecia Market by Disease Type 11.3.7.3.2 India Alopecia Market by Drug Type 11.3.7.3.3 India Alopecia Market by Route of Administration 11.3.7.3.4 India Alopecia Market by Distribution Channel 11.3.7.4 Japan Alopecia Market 11.3.7.4.1 Japan Alopecia Market by Disease Type 11.3.7.4.2 Japan Alopecia Market by Drug Type 11.3.7.4.3 Japan Alopecia Market by Route of Administration 11.3.7.4.4 Japan Alopecia Market by Distribution Channel 11.3.7.5 South Korea Alopecia Market 11.3.7.5.1 South Korea Alopecia Market by Disease Type 11.3.7.5.2 South Korea Alopecia Market by Drug Type 11.3.7.5.3 South Korea Alopecia Market by Route of Administration 11.3.7.5.4 South Korea Alopecia Market by Distribution Channel 11.4. MIDDLE EAST AND AFRICA 11.4.1 Middle East and Africa Alopecia Market Overview 11.4.2 Middle East and Africa Alopecia Market Forecasts and Analysis 11.4.3 Middle East and Africa Alopecia Market Forecasts and Analysis - By Disease Type 11.4.4 Middle East and Africa Alopecia Market Forecasts and Analysis - By Drug Type 11.4.5 Middle East and Africa Alopecia Market Forecasts and Analysis - By Route of Administration 11.4.6 Middle East and Africa Alopecia Market Forecasts and Analysis - By Distribution Channel 11.4.7 Middle East and Africa Alopecia Market Forecasts and Analysis - By Countries 11.4.7.1 South Africa Alopecia Market 11.4.7.1.1 South Africa Alopecia Market by Disease Type 11.4.7.1.2 South Africa Alopecia Market by Drug Type 11.4.7.1.3 South Africa Alopecia Market by Route of Administration 11.4.7.1.4 South Africa Alopecia Market by Distribution Channel 11.4.7.2 Saudi Arabia Alopecia Market 11.4.7.2.1 Saudi Arabia Alopecia Market by Disease Type 11.4.7.2.2 Saudi Arabia Alopecia Market by Drug Type 11.4.7.2.3 Saudi Arabia Alopecia Market by Route of Administration 11.4.7.2.4 Saudi Arabia Alopecia Market by Distribution Channel 11.4.7.3 U.A.E Alopecia Market 11.4.7.3.1 U.A.E Alopecia Market by Disease Type 11.4.7.3.2 U.A.E Alopecia Market by Drug Type 11.4.7.3.3 U.A.E Alopecia Market by Route of Administration 11.4.7.3.4 U.A.E Alopecia Market by Distribution Channel 11.5. SOUTH AND CENTRAL AMERICA 11.5.1 South and Central America Alopecia Market Overview 11.5.2 South and Central America Alopecia Market Forecasts and Analysis 11.5.3 South and Central America Alopecia Market Forecasts and Analysis - By Disease Type 11.5.4 South and Central America Alopecia Market Forecasts and Analysis - By Drug Type 11.5.5 South and Central America Alopecia Market Forecasts and Analysis - By Route of Administration 11.5.6 South and Central America Alopecia Market Forecasts and Analysis - By Distribution Channel 11.5.7 South and Central America Alopecia Market Forecasts and Analysis - By Countries 11.5.7.1 Brazil Alopecia Market 11.5.7.1.1 Brazil Alopecia Market by Disease Type 11.5.7.1.2 Brazil Alopecia Market by Drug Type 11.5.7.1.3 Brazil Alopecia Market by Route of Administration 11.5.7.1.4 Brazil Alopecia Market by Distribution Channel 11.5.7.2 Argentina Alopecia Market 11.5.7.2.1 Argentina Alopecia Market by Disease Type 11.5.7.2.2 Argentina Alopecia Market by Drug Type 11.5.7.2.3 Argentina Alopecia Market by Route of Administration 11.5.7.2.4 Argentina Alopecia Market by Distribution Channel
12. INDUSTRY LANDSCAPE 12.1. MERGERS AND ACQUISITIONS 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 12.3. NEW PRODUCT LAUNCHES 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ALOPECIA MARKET, KEY COMPANY PROFILES 13.1. CAPILLUS 13.1.1. Key Facts 13.1.2. Business Description 13.1.3. Products and Services 13.1.4. Financial Overview 13.1.5. SWOT Analysis 13.1.6. Key Developments 13.2. SUN PHARMACEUTICAL INDUSTRIES LTD. 13.2.1. Key Facts 13.2.2. Business Description 13.2.3. Products and Services 13.2.4. Financial Overview 13.2.5. SWOT Analysis 13.2.6. Key Developments 13.3. CIPLA INC. 13.3.1. Key Facts 13.3.2. Business Description 13.3.3. Products and Services 13.3.4. Financial Overview 13.3.5. SWOT Analysis 13.3.6. Key Developments 13.4. MERCK AND CO., INC. 13.4.1. Key Facts 13.4.2. Business Description 13.4.3. Products and Services 13.4.4. Financial Overview 13.4.5. SWOT Analysis 13.4.6. Key Developments 13.5. TRANSITIONS HAIR 13.5.1. Key Facts 13.5.2. Business Description 13.5.3. Products and Services 13.5.4. Financial Overview 13.5.5. SWOT Analysis 13.5.6. Key Developments 13.6. FOLLICA, INC. 13.6.1. Key Facts 13.6.2. Business Description 13.6.3. Products and Services 13.6.4. Financial Overview 13.6.5. SWOT Analysis 13.6.6. Key Developments 13.7. JOHNSON AND JOHNSON SERVICES, INC. 13.7.1. Key Facts 13.7.2. Business Description 13.7.3. Products and Services 13.7.4. Financial Overview 13.7.5. SWOT Analysis 13.7.6. Key Developments 13.8. CONCERT PHARMACEUTICALS 13.8.1. Key Facts 13.8.2. Business Description 13.8.3. Products and Services 13.8.4. Financial Overview 13.8.5. SWOT Analysis 13.8.6. Key Developments 13.9. HCELL INC. 13.9.1. Key Facts 13.9.2. Business Description 13.9.3. Products and Services 13.9.4. Financial Overview 13.9.5. SWOT Analysis 13.9.6. Key Developments 13.10. GLAXOSMITHKLINE PLC. 13.10.1. Key Facts 13.10.2. Business Description 13.10.3. Products and Services 13.10.4. Financial Overview 13.10.5. SWOT Analysis 13.10.6. Key Developments
14. APPENDIX 14.1. ABOUT THE INSIGHT PARTNERS 14.2. GLOSSARY OF TERMS
The List of Companies
1. CAPILLUS2. Sun Pharmaceutical Industries Ltd.3. Cipla Inc.4. Merck and Co., Inc.5. Transitions Hair6. Follica, Inc.7. Johnson and Johnson Services, Inc.8. Concert Pharmaceuticals9. HCell Inc.10. GlaxoSmithKline plc.
